| 4IFC: reference: Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approaches., Gao Q, Mechin I, Kothari N, Guo Z, Deng G, Haas K, McManus J, Hoffmann D, Wang A, Wiederschain D, Rocnik J, Czechtizky W, Chen X, McLean L, Arlt H, Harper D, Liu F, Majid T, Patel V, Lengauer C, Garcia-Echeverria C, Zhang B, Cheng H, Dorsch M, Huang SM, J Biol Chem. 2013 Sep 3. PMID: 24003220 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).